October 25, 2018
Astellas US LLC et al v. Hospira, Inc.
Case Number:
1:18-cv-01675
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Cooley LLP
- Duane Morris
- Fish & Richardson
- Heyman Enerio
- Morris James
- Morris Nichols
- Phillips McLaughlin
- Potter Anderson
- Shaw Keller
- Young Conaway
Companies
- Apotex Inc.
- Astellas Pharma Inc.
- Curia Global Inc.
- Dr. Reddy's Laboratories Ltd.
- Gilead Sciences Inc.
- Gland Pharma Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hospira Inc.
- Sandoz International GmbH
- Sun Pharmaceutical Industries Ltd.
- Wockhardt Bio AG
- Wockhardt USA LLC
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 27, 2022
Fed. Circ. Temporarily Pauses Launch Of Generic Lexiscan
The Federal Circuit imposed a temporary stay Tuesday that blocks Pfizer from launching a generic version of the coronary artery test Lexiscan, even though a Delaware federal judge ruled earlier this year that the new drug wouldn't actually infringe any patents Gilead has on Lexiscan.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login